Many of us probably have never heard of Jerome Horwitz, but there are few who have done as much for public health and infection prevention as he has. Dr. Horwitz synthesized the nucleoside analog reverse transcriptase inhibitors, AZT, d4t and ddC back in the 1960's as potential chemotherapeutic agents. They were pulled off the shelves in the 1980's and 1990's and proved to be some of the first successful antivirals effective against HIV and served as a model for future discoveries. Sadly, he never obtained patents on these agents and thus, someone else profited from his genius and efforts. To read more about Dr. Horwitz, please read the obituary in the NYT.
A couple errors are present in the current obit: Dr. Horwitz discovered zalcitabine (ddC) and not didanosine (ddI) and it is stuvadine (d4T) and not "stauvidine" that he synthesized.
Pondering vexing issues in infection prevention and control
Subscribe to:
Post Comments (Atom)
OSHA! OSHA! OSHA!
In many parts of the country, as rates of COVID-19 are declining and vaccination coverage is increasing (albeit with substantial variati...
-
In many parts of the country, as rates of COVID-19 are declining and vaccination coverage is increasing (albeit with substantial variati...
-
This is a guest post by Jorge Salinas, MD, Hospital Epidemiologist at the University of Iowa Hospitals & Clinics. There is virtually no...
-
I’m surprised that we can’t stop arguing about the modes of SARS-CoV-2 transmission, despite the fact that most experts (including our frie...

No comments:
Post a Comment
Thanks for submitting your comment to the Controversies blog. To reduce spam, all comments will be reviewed by the blog moderator prior to publishing. However, all legitimate comments will be published, whether they agree with or oppose the content of the post.